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Abstract
Objective: This study describes the implementation and evaluation of revised opioid 
overdose prevention and education of naloxone training for law enforcement officers 
(LEOs) that added: (1) a recovery testimony and (2) the process for deputy- initiated 
referrals postnaloxone administration.
Design and Sample: Evaluation regarding the naloxone training included a pre- and 
postopioid overdose knowledge surveys (N = 114) and subsequent 1- year postnalox-
one training outcomes.
Results: Pre- and posttest scores for all knowledge outcome measures were statisti-
cally significant (p < .001) with favorable comments pertaining to the recovery testi-
mony. Out of 31 individuals who received naloxone, 6 individuals (19.4%) continue to 
be in treatment or received some treatment services. The most common symptoms 
reported were unconsciousness/unresponsiveness (40.5%), abnormal breathing pat-
terns (24.3%), and blue lips (16.2%). The majority of the calls (65.6%) were to a resi-
dential area, and the time for naloxone revival ranged <1–10 min (M = 3.48; SD = 2.27).
Conclusion: As nearly 20% of individuals sought treatment after a LEO- initiated refer-
ral, it is recommended that other agencies consider the referral process into the train-
ing. Future research will investigate the impact of the recovery testimony in reducing 
the stigma of addiction.
K E Y W O R D S
evaluation, law enforcement officers, naloxone, opioid overdose prevention and education
1  | BACKGROUND
Deaths due to opioid overdoses have reached epidemic proportions 
in the United States. Much of the rise in opioid overdose fatalities has 
been due to deaths from prescription opioid pain killers combined 
with a sharp rise in deaths related to heroin and synthetic opioid pain 
relievers other than methadone (Rudd, Aleshire, Zibbell, & Gladden, 
2016). Deaths from opioid overdose occur via respiratory depression, 
occur minutes to hours after opioid ingestion (Sporer, 2003; Zador, 
Sunjic, & Darke,1996), and are witnessed by others (Darke & Zador, 
1996; Paulozzi, 2012). Therefore, opportunities exist for prevention 
and intervention. One key antidote to reverse opioid overdoses is nal-
oxone hydrochloride. Naloxone is a pure opioid antagonist, reversing 
the respiratory depression caused by opioids, and has been used by 
medical personnel for more than 40 years (Wermeling, 2015). It is a 
nonscheduled drug that comes in a variety of formulations (intrave-
nous, intramuscular, subcutaneous, and intranasal [IN]), has no effect 
if no opioids are in the body, lasts for 30–81 min, and has no potential 
for abuse (Darke & Hall, 1997).
With increasing rates of opioid overdose mortality, one method 
to prevent opioid overdose- related deaths has been the implemen-
tation of community- wide initiatives and trainings to increase access 
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to and distribution of naloxone. Since 1996, over 640 community or-
ganizations have provided naloxone kits to over 152,000 laypersons 
resulting in nearly 26,500 opioid overdose reversals (Wheeler, Jones, 
Gilbert, & Davidson, 2015). Recent attention has focused on training 
law enforcement officers (LEOs) to administer naloxone as they are 
often first to arrive at the scene of an overdose, especially in rural 
regions. As “time is brain” when it comes to opioid overdoses, the 
quicker naloxone is administered, the less likelihood of damage to the 
person’s brain and body. As of December 2016, there are 1,214 law 
enforcement agencies trained to administer naloxone (Childs, 2016).
Naloxone training for LEOs has been shown to increase opioid 
overdose knowledge, improve attitudes related to competency, and 
address concerns about naloxone administration (Purviance, Ray, 
Tracy, & Southard, 2016; Wagner, Bovet, Haynes, Joshua, & Davidson, 
2016). Moving beyond education, LEOs can effectively demonstrate 
the skills to reverse opioid overdoses in real- world settings, reduce 
opioid overdose mortality in a Midwest state postnaloxone implemen-
tation, and initiate referrals to assist people into treatment services 
postnaloxone administration (Fisher, O’Donnell, Ray, & Rusyniak, 
2016; Rando, Broering, Olson, Marco, & Evans, 2015; Wagner et al., 
2016).
Statistics from 1999 to 2012 show that the number of uninten-
tional drug poisoning deaths in Michigan has nearly quadrupled from 
235 to 941 deaths per year (MDCH, 2014). Washtenaw County is not 
immune to this opioid epidemic. From 2012 to 2014, there was a two-
fold increase in opioid overdose- related deaths (from 30 to 60 deaths). 
In response, the Washtenaw County Office (WCO) implemented nal-
oxone training for its LEOs in August 2015. The purpose of this de-
scriptive study was twofold. We will describe the implementation of 
LEO naloxone training that added two topics to the standard naloxone 
education curriculum: (1) a recovery testimony and (2) the process 
for deputy- initiated referrals postnaloxone administration and subse-
quent effects of naloxone training over a 12- month period.
2  | METHODS
The WCO has 109 deputies that were required to undergo nalox-
one training. Out of 109 deputies, 87% are male (N = 95) and 13% 
are female (N = 14), with an age range of 21–58 years old (M = 40; 
SD = 8.2). The mean number of years working as an officer was 13.33 
(SD = 8.35), with a range from new hire to 31 years. Five separate 
trainings were conducted in a large conference room at the WCO 
office that lasted for 45–60 min. All trainings were co- taught by a 
Lieutenant (second author) and a doctorally prepared nurse practi-
tioner (first author) who has been teaching opioid overdose preven-
tion education to community organizations since 2013.
2.1 | Law enforcement naloxone training curriculum
The training instructional curriculum was developed and modified 
using materials from the Harm Reduction Coalition. The curriculum 
content included benefits and concerns regarding naloxone, myths 
and facts about overdoses, Michigan legislation, medical facts about 
opioids, overdose risk factors, overdose symptom recognition, and 
protocol for naloxone administration. Included in the training were 
the documentation procedures for reporting an overdose, adminis-
tering naloxone, and storing naloxone. The didactic content was de-
livered through a PowerPoint presentation, and included interactive 
components through small group discussion, video presentations, and 
periodic questions to engage the audience’s comprehension and ex-
periences. After the didactic content was delivered, the LEOs under-
went a simulated opioid overdose scenario where each LEO practiced 
assembling and administering the non- FDA- approved IN naloxone 
on a mannequin. Each deputy was given a red naloxone bag that 
contained instructions on assembling the non- FDA- approved IN na-
loxone, referral procedures, nasal atomizer, and one dose of the non- 
FDA- approved IN naloxone immediately after the training. Naloxone 
was purchased through a State- awarded grant from a local community 
organization.
Two unique components were added to enhance our naloxone 
training for LEOs: (1) instructions for LEOs to contact a case manager 
from a local substance use disorder treatment program to connect 
with the person rescued at the hospital for further assessment and 
treatment options, and (2) testimony from a person in long- term re-
covery who shared her personal story of the impact a LEO had in her 
decision to seek substance use treatment. Specifically, inside each red 
naloxone bag contained telephone numbers for case managers to local 
treatment facilities. The LEOs were instructed to call a case manager 
from a local substance use treatment facility postnaloxone administra-
tion. The case manager would then meet with the overdosed person 
at the emergency department for follow- up. For the complete training 
material, contact the first author.
2.2 | Measures
2.2.1 | Naloxone training evaluation measures
Prior to the naloxone training, each deputy completed a pre-
knowledge survey based on a 1- to 5- point Likert Scale (1 = Least 
Knowledge to 5 = Most Knowledge) regarding his or her knowledge 
of the benefit of overdose prevention as it applies to LEOs and the 
community, information related to opioid overdoses (risk factors, 
signs and symptoms), information related to naloxone and how it 
reverses an overdose, how to prepare the IN naloxone using the 
mucosal atomizer device, how to administer naloxone to a subject 
having an overdose, and information related to WCO’s procedural 
guideline related to naloxone (administration, storage, documen-
tation, replacement). After the naloxone training, the LEOs took a 
10- point true and false quiz to receive their certification and com-
pleted the postknowledge survey. Included in the postsurvey was a 
general training evaluation that was based on a 1- to 5- point Likert 
Scale (1 = Strongly Disagree to 5 = Strongly Agree) regarding train-
ers’ communication effectiveness, usefulness of training materials, 
and hands- on simulation. It also included a section for qualitative 
comments.
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2.2.2 | Postnaloxone administration outcome  
measures
Personal and contextual characteristics surrounding the overdose were 
collected through standard LEO documentation after a 12- month pe-
riod. The LEO report was de- identified and included gender, age, gen-
eral description of the location, number of naloxone doses administered, 
time to revive the patient postnaloxone administration, involvement of 
emergency medical technicians, signs of overdose, and the LEO’s free- 
text description regarding the scenario surrounding the overdose. The 
postnaloxone administration treatment outcome data was collected 
through a community health database that was connected to substance 
use treatment facilities to see whether the person was in active treat-
ment after the overdose, or not in treatment. All data collected were 
de- identified prior to the data analyses that were completed by the first 
author.
2.3 | Analysis
Descriptive statistics were calculated for all measures, including the 
postnaloxone administration data. A paired samples t test was con-
ducted to compare the LEO’s knowledge scores regarding the objec-
tives of the Naloxone Training before and after training. All results 
were entered into SPSS Version 23 and analyzed. As the study was 
a program evaluation and data were de- identified prior to analyses, 




Out of 109 deputies trained, 11 surveys were not completed in their 
entirety; therefore, we had a full survey response rate of 89% (n = 98). 
A majority of the LEOs had witnessed an opioid overdose prior to 
the naloxone training (n = 72; 73%). As displayed in Table 1, there are 
statistically significant differences, at the .001 significance level even 
after Bonferroni adjustment for multiple testing, in all preknowledge 
to postknowledge scores. The deputies perceived that the trainers 
communicated effectively (answered all questions M = 4.93, SD = .29; 
communicated clearly M = 4.96, SD = .19), the training materials 
were helpful (M = 4.94, SD = .24), and hands- on simulation was use-
ful (M = 4.93, SD = .29). Qualitatively, the participants shared, “Great 
presentation and speakers.” “Straight forward and to the point. Great.” 
“Good job teaching a good subject.” “I enjoyed the stories of the re-
covering addicts.” “This was an excellent course!” “The recovering ad-
dicts were very instrumental in this training.”
3.2 | Postnaloxone administration contextual 
characteristics
Since the Naloxone Training from August 2015 to August 2016, there 
have been 32 overdose encounters where the LEOs administered 
naloxone. Out of 32 naloxone administrations, one case resulted in 
fatality where the patient was transported to the hospital, but died 
in the hospital the next day (see Table 2). Therefore, WCSO LEOs 
successfully reversed 31 overdoses in 1 year following the naloxone 
training. The majority of the patients who were rescued were male 
(n = 26; 81%) with a mean age of 31 years (SD = 7.85). Three out of 32 
naloxone administrations required a second dose of naloxone and the 
majority of the calls (65.6%) were to a residential area. The time for na-
loxone revival ranged <1–10 min (M = 3.48; SD = 2.27). Two out of 32 
overdose encounters were repeat naloxone administrations. The most 
common clinical signs and symptoms reported by LEOs were uncon-
sciousness/unresponsiveness, abnormal breathing patterns, and blue 
lips (see Table 3). No arrests were made at the scene of the overdoses.
3.3 | Postnaloxone administration referral 
treatment outcomes
Out of 31 individuals whose overdoses were reversed, 6 individu-
als (19.4%) continue to be in treatment or received some treatment 
TABLE  1 Descriptive statistics and paired samples t test results for intranasal naloxone training (N = 98, df = 97)
Outcome
Pretest Posttest
95% CI r tM (SD) M (SD)
Recognizing the signs, symptoms and risk factors of an 
opioid overdose
2.66 (1.23) 4.7 (.53) −2.32, −1.83 .21 −16.67*
Identifying the benefits of overdose prevention as it applies 
to law enforcement personnel and the community
2.68 (1.24) 4.77 (.57) −2.34, −1.83 .16 −16.08*
Understanding what naloxone is and how it reverses an 
overdose
1.74 (1.04) 4.82 (.44) −3.31, −2.83 −.15 −25.63*
How to assemble and prepare the intranasal naloxone 1.12 (.56) 4.96 (.25) −3.96, −3.71 −.04 −61.18*
How to administer naloxone to a subject having an 
overdose
1.22 (.65) 4.95 (.26) −3.87, −3.58 −.05 −51.58*
Familiarity with WCSO’s procedural guideline related to 
naloxone (administration, storage, replacement)
1.05 (.27) 4.77 (.51) −3.84, −3.60 −.14 −59.68*
*p < .001.
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services postnaloxone administration, 19 (61.3%) individuals did not 
receive treatment, and 6 (19.4%) individuals were from different 
counties and treatment records were not available.
4  | DISCUSSION
The current study demonstrated that naloxone training improved 
opioid overdose knowledge, which was then applied effectively in 
real- world settings, and that LEO referrals postnaloxone reversals 
contributed to assisting people into treatment services. Almost 20% 
of those rescued entered into substance use treatment postreversal 
according to our study. Our study is one of the few studies to inves-
tigate postnaloxone administration entry into treatment as a result of 
a LEO referral to a case manager and is similar to other studies that 
indicate one out of four injection drug users sought treatment within 
30 days postoverdose and those who sought treatment were five 
times more likely to enter into treatment if someone talked to them 
about drug treatment after an overdose than those who did not seek 
treatment (Pollini et al., 2006). Similar results were shown by Wagner 
et al. (2016), which demonstrated that three out of nine overdose vic-
tims entered into treatment due to a LEO referral.
These studies underscore the importance of referrals by LEOs 
and the possibility of creating a defining or teachable moment for 
the person revived to guide them into treatment. An overdose sit-
uation also creates an opportunity for LEOs to engage with the 
person rescued and other witnesses for further follow- up in the 
community. This sentiment along with receiving additional com-
munication strategies was expressed through LEO interviews 
conducted by Green et al. (2013) in order to improve community- 
police relationships and prevent overdoses. Promising techniques 
such as brief motivational interviewing have been found to reduce 
overdose risk behaviors and nonmedical opioid use among adults 
with a history of prescription opioid misuse (Bohnert et al., 2016). 
Future research can examine if motivational interviewing skills can 
be employed by LEOs to further engage with the rescued person 
and other witnesses, as well as its role in assisting people into treat-
ment after reversals.
Unlike the standard opioid overdose prevention and education 
curriculum, we included a testimony from a person in long- term re-
covery who shared how an officer impacted her life and helped her 
to be aware of her addiction which led to her seeking treatment. The 
testimony was included to reduce the stigma of addiction and help 
officers see that recovery is possible. Initial qualitative comments sug-
gest that the testimony was helpful for the training, but we did not 
quantitatively collect data to examine if LEOs perceptions of addiction 
changed after hearing the recovery testimony. Research is currently 
being conducted to qualitatively evaluate the officers’ perception of 
the naloxone training curriculum. Information from the officers that 
have utilized naloxone in the field, including their perceptions about 
drug users and the recovery testimony as a result of the training, will 
be used to develop an evidence- based curriculum for the LEOs, which 
will be translated into web- based naloxone training. The web- based 
naloxone training allows for more efficient process of re- certification 
and greater dissemination of training for LEOs to deliver the life- saving 
naloxone medication.
Although prior studies have reported pre- and postopioid overdose 
attitude and knowledge measures after naloxone training for LEOs 
(Purviance et al., 2016; Ray, O’Donnell, & Kahre, 2015; Saucier, Zaller, 
Macmadu, & Green, 2016; Wagner et al., 2016), few studies have ex-
amined postnaloxone administration data and LEOs’ actions through 
LEO documentation reports. Fisher et al. (2016) was the first study to 
demonstrate the most common clinical signs of opioid overdose that 
resulted in administration of naloxone by the LEOs, and the disposition 
of the patient postnaloxone administration. The LEO documentation 
reports provide basic understanding of the contextual factors regard-
ing opioid overdose and naloxone administration, and indicate topics 
to emphasize or modify in subsequent trainings for LEOs. For instance, 






1 dose 29 90.6
2 doses 3 9.4
Time to revivalb
<1 min 3 10.7
1–2 min 8 28.5
3–4 min 7 25
5 min 7 25
>5 min 3 7.2
Location
Residence 21 65.6
Public parking lot 6 18.8
Street 2 6.3
Other (under bridge, public 
parking lot, patrol car)
3 9.4
aOne overdose resulted in fatality.
bFour missing data.
TABLE  3 Signs and symptoms of overdose reporteda (N = 37)
n %
Unconscious 15 40.5
Abnormal breathing 9 24.3
Blue lips 6 16.2
Gurgling 2 5.4
Weak pulse 2 5.4
Half- open eyes 3 8.2
aSigns and symptoms of overdose are not mutually exclusive.
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the 2 mg IN naloxone was effective in reversing the effects of most 
opioid overdoses for our suburban Midwest county until EMS arrived 
to provide additional medical support, the time to revival was around 
3 min, and the most common signs of overdose included unconscious-
ness, abnormal breathing, and blue lips. This knowledge can be used to 
tailor future trainings. In addition, 20% of LEO- initiated referrals led to 
some form of substance use treatment. This information can be used 
to encourage LEOs in future trainings that people do seek treatment 
after an overdose and LEOs actions can make a significant impact in a 
person’s recovery.
However, with increasing reports of heroin mixed with fentanyl 
and carfentanil found in surrounding counties along with the time 
and dexterity required to assemble the 2 mg IN naloxone, this may 
suggest utilizing a higher formulation of IN naloxone that is FDA- 
approved for future naloxone trainings. The fact that over 60% of the 
overdoses occurred in a person’s home further supports community- 
wide training for laypersons. From 1996 to 2014, community opioid 
overdose prevention programs have trained and dispensed nalox-
one kits to over 152,000 community laypersons (excluding first re-
sponders) and have reported over 26,400 reversals (Wheeler et al., 
2015). Training laypersons to recognize opioid overdoses and admin-
ister naloxone can save more lives even before the arrival of first 
responders.
Our study is limited by its design, small sample size, and data col-
lection methods. The study was designed to evaluate the initial pilot 
naloxone training for LEOs in a predominantly suburban Midwest 
county. Due to a small sample size, the results are not generalizable 
to other locations. The pre- and postknowledge measures were broad 
general questions and did not specifically ask questions related to opi-
oid overdose knowledge. However, all LEOs passed the 10- item true 
and false test that assessed for specific opioid overdose knowledge 
after the training.
We did not collect data from the local emergency medical services 
(EMS), which could have provided additional insights into overdose 
scenarios such as other medical supportive services provided like oxy-
genation, additional naloxone doses and routes, and situations where 
EMS arrived first and administered naloxone. Although we evaluated 
entry into treatment for those who were revived and referred by a LEO 
to a case manager for treatment, we did not obtain specific treatment 
data such as what type of treatment, duration of treatment, reasons to 
enter into treatment, etc. We do not know based on LEO documen-
tation reports and from the community health database what factors 
influenced the person who was revived to seek treatment. Future re-
search should investigate the best evidence- based outreach practices 
for postnaloxone reversals.
Despite these limitations, we described the implementation of a 
modified naloxone training curriculum for LEOs that included a re-
covery testimony and instructions for deputy- initiated referrals post-
naloxone administration. We further examined personal, contextual 
characteristics surrounding overdoses, and treatment outcomes as 
a result of deputy referral postnaloxone reversal over a 12- month 
period. The fact that people entered into treatment after a deputy- 
initiated referral indicates the need for further investigation into the 
role that LEOs can play in opioid overdose prevention, and extend-
ing into public health efforts to improve the health of the community 
through reducing opioid overdose mortality and morbidity and im-
proving public relations.
Research is ongoing to evaluate if the recovery testimony had an 
impact on LEOs’ perceptions about people who use drugs. Equipping 
LEOs with naloxone is one key aspect of fighting against the opioid 
epidemic and a critical component to recovery, but more research is 
needed to identify best practices for postnaloxone administration to 
assist drug users’ entry into treatment and sustain recovery.
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